Literature DB >> 35477802

The role of miR-153 and related upstream/downstream pathways in cancers: from a potential biomarker to treatment of tumor resistance and a therapeutic target.

Vahab Alamdari-Palangi1, Khojaste Rahimi Jaberi2, Abbas Rahimi Jaberi2,3, Seyed Mohammad Gheibihayat4, Majid Akbarzadeh5, Amir Tajbakhsh6, Amir Savardashtaki7,8.   

Abstract

MicroRNAs (miRNAs/miRs) are small non-coding RNAs that have a multifunction and play essential roles in gene regulation. Their dysregulation is associated with several human cancers. MiR-153 has a critical role in many biological processes, such as suppressing tumor growth (mostly), responses to treatment, and drug resistance. However, miR-153 in some cancers shows a different role as an oncogene, such as prostate. The miR-153 expression can be regulated by several regulators, such as lncRNAs and circular RNAs. By discovering the target factors for miR-153, it may be possible to approach early diagnosis, reversing drug resistance, and treatment of cancers. This will help choose the precise treatment for the patient and not incur additional costs in treatment. Thus, we attempt to summarize the current situation and potential development prospects about the role of miR-153 in cancers. The miR-153 paly an important role in cancers and can be used for diagnosis and prognosis.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Biomarker; Circular RNA; Drug resistance; Long noncoding RNA; MiR-153; Noninvasive; Radiotherapy; Therapeutics

Mesh:

Substances:

Year:  2022        PMID: 35477802     DOI: 10.1007/s12032-022-01653-8

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  4 in total

1.  MicroRNA-153-3p enhances the sensitivity of chronic myeloid leukemia cells to imatinib by inhibiting B-cell lymphoma-2-mediated autophagy.

Authors:  Yu-Ling Li; Jia-Ming Tang; Xiao-Yun Chen; Bing Luo; Guo-Hua Liang; Qian Qu; Zi-Yuan Lu
Journal:  Hum Cell       Date:  2020-04-27       Impact factor: 4.174

2.  Reduced accumulation of specific microRNAs in colorectal neoplasia.

Authors:  Michael Z Michael; Susan M O' Connor; Nicholas G van Holst Pellekaan; Graeme P Young; Robert J James
Journal:  Mol Cancer Res       Date:  2003-10       Impact factor: 5.852

3.  Effect of miR-223 on thrombophlebitis rats through regulating Toll-like receptor signaling pathway.

Authors:  H-L Li; Y-H Liu; X-B Shang; Y Li; L Feng; D-L Qi
Journal:  Eur Rev Med Pharmacol Sci       Date:  2020-02       Impact factor: 3.507

Review 4.  The growth of siRNA-based therapeutics: Updated clinical studies.

Authors:  M May Zhang; Raman Bahal; Theodore P Rasmussen; José E Manautou; Xiao-Bo Zhong
Journal:  Biochem Pharmacol       Date:  2021-01-26       Impact factor: 6.100

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.